Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
- PMID: 28385310
- DOI: 10.1016/j.jacc.2017.01.052
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Abstract
Background: Despite being widely recognized as the most common form of secondary hypertension, among the general hypertensive population the true prevalence of primary aldosteronism (PA) and its main subtypes, aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH), remains a matter of debate.
Objectives: This study sought to determine the prevalence and clinical phenotype of PA in a large cohort of unselected patients with hypertension, consecutively referred to our hypertension unit, by 19 general practitioners from Torino, Italy.
Methods: Following withdrawal from all interfering medications, patients were screened for PA using the ratio of serum aldosterone to plasma renin activity. PA was diagnosed according to Endocrine Society guidelines. The diagnosis was confirmed or excluded by an intravenous saline infusion test or captopril challenge test and subtype differentiation was performed by adrenal computed tomography scanning and adrenal vein sampling, using strict criteria to define successful cannulation and lateralization of aldosterone production.
Results: A total of 1,672 primary care patients with hypertension (569 newly diagnosed and 1,103 patients already diagnosed with arterial hypertension) were included in the study. A total of 99 patients (5.9%) were diagnosed with PA and conclusive subtype differentiation by adrenal vein sampling was made in 91 patients (27 patients with an APA and 64 patients with BAH). The overall prevalence of PA increased with the severity of hypertension, from 3.9% in stage 1 hypertension to 11.8% in stage 3 hypertension. Patients with PA more frequently displayed target organ damage and cardiovascular events compared with those without PA, independent of confounding variables.
Conclusions: Our results demonstrated that PA is a frequent cause of secondary hypertension, even in the general population of patients with hypertension, and indicates that most of these patients should be screened for PA.
Keywords: adrenal vein sampling; aldosterone-producing adenoma; bilateral adrenal hyperplasia; hypertension; renin.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives.J Am Coll Cardiol. 2017 Apr 11;69(14):1821-1823. doi: 10.1016/j.jacc.2017.02.041. J Am Coll Cardiol. 2017. PMID: 28385311 No abstract available.
-
Call for screening for primary aldosteronism: an underdiagnosed and treatable disease.J Thorac Dis. 2018 Feb;10(2):557-559. doi: 10.21037/jtd.2018.01.71. J Thorac Dis. 2018. PMID: 29607111 Free PMC article. No abstract available.
Similar articles
-
What We Know about and What Is New in Primary Aldosteronism.Int J Mol Sci. 2024 Jan 11;25(2):900. doi: 10.3390/ijms25020900. Int J Mol Sci. 2024. PMID: 38255973 Free PMC article. Review.
-
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300. doi: 10.1016/j.jacc.2006.07.059. Epub 2006 Nov 13. J Am Coll Cardiol. 2006. PMID: 17161262
-
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.Hypertension. 2012 Aug;60(2):431-6. doi: 10.1161/HYPERTENSIONAHA.112.195891. Epub 2012 Jun 25. Hypertension. 2012. PMID: 22733469
-
Prevalence of primary aldosteronism in primary care: a cross-sectional study.Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15. Br J Gen Pract. 2018. PMID: 29335324 Free PMC article.
-
Primary aldosteronism: who should be screened?Horm Metab Res. 2012 Mar;44(3):163-9. doi: 10.1055/s-0031-1295409. Epub 2011 Nov 25. Horm Metab Res. 2012. PMID: 22120135 Review.
Cited by
-
Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study.Hypertens Res. 2024 Mar 8. doi: 10.1038/s41440-024-01594-x. Online ahead of print. Hypertens Res. 2024. PMID: 38454147
-
Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.Endocrine. 2024 Mar 6. doi: 10.1007/s12020-024-03751-1. Online ahead of print. Endocrine. 2024. PMID: 38448679 Review.
-
Sex-specific association of low-renin hypertension with metabolic and musculoskeletal health in Korean older adults.Front Public Health. 2024 Feb 12;12:1250945. doi: 10.3389/fpubh.2024.1250945. eCollection 2024. Front Public Health. 2024. PMID: 38410670 Free PMC article.
-
Comparison of plasma aldosterone measured by chemiluminescence immunoassay and liquid chromatography-tandem mass spectrometry in screening test for primary aldosteronism.Pract Lab Med. 2024 Jan 19;39:e00361. doi: 10.1016/j.plabm.2024.e00361. eCollection 2024 Mar. Pract Lab Med. 2024. PMID: 38318433 Free PMC article.
-
What We Know about and What Is New in Primary Aldosteronism.Int J Mol Sci. 2024 Jan 11;25(2):900. doi: 10.3390/ijms25020900. Int J Mol Sci. 2024. PMID: 38255973 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
